Yan MD - Search Results

1

Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma.

Shih YL, Hsieh CB, Yan MD, Tsao CM, Hsieh TY, Liu CH, Lin YW. Shih YL, et al. Among authors: yan md. J Gastroenterol Hepatol. 2013 Mar;28(3):551-9. doi: 10.1111/jgh.12078. J Gastroenterol Hepatol. 2013. PMID: 23215838

2

SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.

Shih YL, Hsieh CB, Lai HC, Yan MD, Hsieh TY, Chao YC, Lin YW. Shih YL, et al. Among authors: yan md. Int J Cancer. 2007 Sep 1;121(5):1028-35. doi: 10.1002/ijc.22750. Int J Cancer. 2007. PMID: 17443492

3

Promoter methylation of SFRPs gene family in cervical cancer.

Chung MT, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Chu TY, Lai HC, Lin YW. Chung MT, et al. Among authors: yan md. Gynecol Oncol. 2009 Feb;112(2):301-6. doi: 10.1016/j.ygyno.2008.10.004. Epub 2008 Nov 26. Gynecol Oncol. 2009. PMID: 19038436

4

The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma.

Lin YW, Yan MD, Shih YL, Hsieh CB. Lin YW, et al. Among authors: yan md. Eur J Cancer. 2009 Jul;45(11):2041-9. doi: 10.1016/j.ejca.2009.04.012. Epub 2009 May 4. Eur J Cancer. 2009. PMID: 19410446

5

SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.

Tsao CM, Yan MD, Shih YL, Yu PN, Kuo CC, Lin WC, Li HJ, Lin YW. Tsao CM, et al. Among authors: yan md. Hepatology. 2012 Dec;56(6):2277-87. doi: 10.1002/hep.25933. Hepatology. 2012. PMID: 22767186

6

SOX1 suppresses cell growth and invasion in cervical cancer.

Lin YW, Tsao CM, Yu PN, Shih YL, Lin CH, Yan MD. Lin YW, et al. Among authors: yan md. Gynecol Oncol. 2013 Oct;131(1):174-81. doi: 10.1016/j.ygyno.2013.07.111. Epub 2013 Aug 6. Gynecol Oncol. 2013. PMID: 23927962

7

Promoter methylation of SFRP3 is frequent in hepatocellular carcinoma.

Lin YW, Shih YL, Lien GS, Suk FM, Hsieh CB, Yan MD. Lin YW, et al. Among authors: yan md. Dis Markers. 2014;2014:351863. doi: 10.1155/2014/351863. Epub 2014 Jan 21. Dis Markers. 2014. PMID: 24591760 Free PMC article.

8

Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.

Kuo CC, Shih YL, Su HY, Yan MD, Hsieh CB, Liu CY, Huang WT, Yu MH, Lin YW. Kuo CC, et al. Among authors: yan md. World J Gastroenterol. 2015 Apr 7;21(13):3960-9. doi: 10.3748/wjg.v21.i13.3960. World J Gastroenterol. 2015. PMID: 25852282 Free PMC article.

9

Quantitative methylation analysis reveals distinct association between PAX6 methylation and clinical characteristics with different viral infections in hepatocellular carcinoma.

Shih YL, Kuo CC, Yan MD, Lin YW, Hsieh CB, Hsieh TY. Shih YL, et al. Among authors: yan md. Clin Epigenetics. 2016 Apr 22;8:41. doi: 10.1186/s13148-016-0208-3. eCollection 2016. Clin Epigenetics. 2016. PMID: 27110298 Free PMC article.

10

SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.

Chung MT, Lai HC, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Liu HS, Chu DW, Lin YW. Chung MT, et al. Among authors: yan md. Gynecol Oncol. 2009 Mar;112(3):646-53. doi: 10.1016/j.ygyno.2008.10.026. Epub 2008 Dec 18. Gynecol Oncol. 2009. PMID: 19095296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters